BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sirmai L, Pelletier AL, Gault N, Zallot C, Bouguen G, Bouchard D, Roland Nicaise P, Peyneau M, Sironneau S, Bittencourt MDC, Petitcollin A, Fernandez P, Roblin X, Siproudhis L, Abramowitz L. Relationship between clinical remission of perianal fistulas in Crohn’s disease and serum adalimumab concentrations: A multi-center cross-sectional study. World J Gastroenterol 2022; 28(9): 961-972 [PMID: 35317057 DOI: 10.3748/wjg.v28.i9.961]
URL: https://www.wjgnet.com/1007-9327/full/v28/i9/961.htm
Number Citing Articles
1
Marta Calvo Moya, Yago González Lama, Belén Ruíz Antorán, Ignacio Omella Usieto, Ismael el Hajra Martinez, Elena Santos Pérez, Belén Menchén Viso, Virginia Matallana Royo, Irene González Partida, Rocío de Lucas Tellez de Meneses, Pablo Bella Castillo, Macarena González Rodriguez, María Isabel Vera Mendoza. Treatment With Adalimumab 80 mg Every Other Week in Inflammatory Bowel Disease: Results of Treatment Intensification in Clinical PracticeCrohn's & Colitis 360 2023; 5(1) doi: 10.1093/crocol/otac051
2
Alyssa M. Parian, Megan Obi, Phillip Fleshner, David A. Schwartz. Management of Perianal Crohn's DiseaseAmerican Journal of Gastroenterology 2023; 118(8): 1323 doi: 10.14309/ajg.0000000000002326
3
Saher‐Zahra Khan, Andrea Arline, Kate M. Williams, Matthew J. Lee, Emily Steinhagen, Sharon L. Stein. The use of core descriptors from the ENiGMA code study in recent literature: a systematic reviewColorectal Disease 2024; 26(3): 428 doi: 10.1111/codi.16893